News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

DNAPrint Pharmaceuticals To Present At NYSSA Biotech/Specialty Pharma Conference



12/5/2006 10:38:34 AM

SARASOTA, FL -- (MARKET WIRE) -- December 05, 2006 -- DNAPrint Genomics, Inc. (OTCBB: DNAG) today announced that Chairman and Chief Medical Officer Hector J. Gomez, M.D., Ph.D., will present an overview of the Company's wholly owned subsidiary DNAPrint Pharmaceuticals, Inc. to investors at the 10th Annual New York Society of Securities Analysts (NYSSA) Biotech/Specialty Pharma Conference on Tues., Dec. 12, 2006 at 1:40 p.m. Eastern time, at the Association's headquarters, 1177 Ave. of the Americas, in New York City.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES